Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Austin Miller

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Plos One|February 6, 2013
Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchymeBarbara A Foster, Kalyan J Gangavarapu, Grinu Mathew, et al.
Surgery|June 29, 2012
Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results Database analysisSai Yendamuri, Laura Caty, Marybeth Pine, et al.
American Journal of Medicine Open|June 11, 2025
Health Disparity Clusters of Off Label Prescriptions for Glucagon-Like Peptide 1 Receptor AgonistsKateri J Spinelli, Allison H Oakes, Shih-Ting Chiu, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 19, 2017
Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancerSai Yendamuri, Adrienne Groman, Austin Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group studyMartee L Hensley, Austin Miller, David M O'Malley, et al.
Gynecologic Oncology|December 31, 2013
LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patientsStacey N Akers, Kirsten Moysich, Wa Zhang, et al.
Sarcoma|December 4, 2015
Homogenous Good Outcome in a Heterogeneous Group of Tumors: An Institutional Series of Outcomes of Superficial Soft Tissue SarcomasValerie Francescutti, Sartaj S Sanghera, Richard T Cheney, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 31, 2014
Oxaliplatin is a safe alternative option for patients with recurrent gynecologic cancers after hypersensitivity reaction to CarboplatinNonna V Kolomeyevskaya, Shashikant B Lele, Austin Miller, et al.
Leukemia Research|May 6, 2021
A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemiaPankit Vachhani, Jeffrey Baron, Craig W Freyer, et al.
Breast Cancer Research and Treatment|January 4, 2011
The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohortFoluso O Ademuyiwa, Austin Miller, Tracey O'Connor, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Plos One|February 6, 2013
Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchymeBarbara A Foster, Kalyan J Gangavarapu, Grinu Mathew, et al.
Surgery|June 29, 2012
Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results Database analysisSai Yendamuri, Laura Caty, Marybeth Pine, et al.
American Journal of Medicine Open|June 11, 2025
Health Disparity Clusters of Off Label Prescriptions for Glucagon-Like Peptide 1 Receptor AgonistsKateri J Spinelli, Allison H Oakes, Shih-Ting Chiu, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 19, 2017
Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancerSai Yendamuri, Adrienne Groman, Austin Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group studyMartee L Hensley, Austin Miller, David M O'Malley, et al.
Gynecologic Oncology|December 31, 2013
LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patientsStacey N Akers, Kirsten Moysich, Wa Zhang, et al.
Sarcoma|December 4, 2015
Homogenous Good Outcome in a Heterogeneous Group of Tumors: An Institutional Series of Outcomes of Superficial Soft Tissue SarcomasValerie Francescutti, Sartaj S Sanghera, Richard T Cheney, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 31, 2014
Oxaliplatin is a safe alternative option for patients with recurrent gynecologic cancers after hypersensitivity reaction to CarboplatinNonna V Kolomeyevskaya, Shashikant B Lele, Austin Miller, et al.
Leukemia Research|May 6, 2021
A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemiaPankit Vachhani, Jeffrey Baron, Craig W Freyer, et al.
Breast Cancer Research and Treatment|January 4, 2011
The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohortFoluso O Ademuyiwa, Austin Miller, Tracey O'Connor, et al.
Pageof 14